Archive for April 2nd, 2012

Optimer Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule …
MarketWatch (press release)
SAN DIEGO, April 2, 2012 /PRNewswire via COMTEX/ — Optimer Pharmaceuticals, Inc. (NASDAQ:OPTR) announced today that on March 30, 2012 the Compensation Committee of its Board of Directors approved the grant of inducement stock options to purchase an …  Read more...